Severe lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child: a case report

Abstract Background Salbutamol is a selective β2-receptor agonist widely used to treat asthma in both emergency and outpatient settings. However, it has been associated with a broad spectrum of side effects. Lactic acidosis and diastolic hypotension are rarely reported together following intermitten...

Full description

Bibliographic Details
Main Authors: Marco Colombo, Anna Plebani, Annalisa Bosco, Massimo Agosti
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Journal of Medical Case Reports
Subjects:
Online Access:https://doi.org/10.1186/s13256-022-03357-z
_version_ 1828347259211743232
author Marco Colombo
Anna Plebani
Annalisa Bosco
Massimo Agosti
author_facet Marco Colombo
Anna Plebani
Annalisa Bosco
Massimo Agosti
author_sort Marco Colombo
collection DOAJ
description Abstract Background Salbutamol is a selective β2-receptor agonist widely used to treat asthma in both emergency and outpatient settings. However, it has been associated with a broad spectrum of side effects. Lactic acidosis and diastolic hypotension are rarely reported together following intermittent salbutamol nebulization in children, even less so at standard therapeutic doses. Case presentation We present the case of a 12-year-old Italian boy, 34 kg body weight, who experienced a serious drug reaction during a moderate asthma exacerbation with associated dehydration (blood urea nitrogen/creatinine 0.25), following intermittent inhaled (0.2 mg at 3-hour intervals—overall 1.4 mg in 24 hours before arrival) and nebulized treatment (3.25 mg at 20-minute intervals in 60 minutes, overall 11.25 mg in our emergency department). The patient developed hyperglycemia (peak concentration 222 mg/dL), hypokalemia (lowest concentration 2.6 mEq/L), electrocardiogram alterations (corrected QT interval 467 ms), long-lasting arterial hypotension despite fluid boluses (lowest value 87/33 mmHg), and elevated blood lactate levels (peak concentration 8.1 mmol/L), following the third nebulized dose. Infections, liver dysfunction, and toxicity following other medications were ruled out. The aforementioned alterations improved within 24 hours after discontinuation of salbutamol. Conclusions We reinforce the message that even the use of intermittent nebulized salbutamol for acute moderate asthma can lead to severe transient complications in children. Then, healthcare providers should pay attention not only in emergency settings, to achieve prompt recognition and proper management of this adverse reaction. Careful reassessment could prevent similar reactions.
first_indexed 2024-04-14T00:37:29Z
format Article
id doaj.art-26510af4d9a04d8181b0a6fac598e5b1
institution Directory Open Access Journal
issn 1752-1947
language English
last_indexed 2024-04-14T00:37:29Z
publishDate 2022-04-01
publisher BMC
record_format Article
series Journal of Medical Case Reports
spelling doaj.art-26510af4d9a04d8181b0a6fac598e5b12022-12-22T02:22:19ZengBMCJournal of Medical Case Reports1752-19472022-04-011611610.1186/s13256-022-03357-zSevere lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child: a case reportMarco Colombo0Anna Plebani1Annalisa Bosco2Massimo Agosti3Pediatric Emergency Department, ASST Sette LaghiPediatric Emergency Department, ASST Sette LaghiPediatric Emergency Department, ASST Sette LaghiDepartment of Neonatology and Pediatrics, ASST Sette LaghiAbstract Background Salbutamol is a selective β2-receptor agonist widely used to treat asthma in both emergency and outpatient settings. However, it has been associated with a broad spectrum of side effects. Lactic acidosis and diastolic hypotension are rarely reported together following intermittent salbutamol nebulization in children, even less so at standard therapeutic doses. Case presentation We present the case of a 12-year-old Italian boy, 34 kg body weight, who experienced a serious drug reaction during a moderate asthma exacerbation with associated dehydration (blood urea nitrogen/creatinine 0.25), following intermittent inhaled (0.2 mg at 3-hour intervals—overall 1.4 mg in 24 hours before arrival) and nebulized treatment (3.25 mg at 20-minute intervals in 60 minutes, overall 11.25 mg in our emergency department). The patient developed hyperglycemia (peak concentration 222 mg/dL), hypokalemia (lowest concentration 2.6 mEq/L), electrocardiogram alterations (corrected QT interval 467 ms), long-lasting arterial hypotension despite fluid boluses (lowest value 87/33 mmHg), and elevated blood lactate levels (peak concentration 8.1 mmol/L), following the third nebulized dose. Infections, liver dysfunction, and toxicity following other medications were ruled out. The aforementioned alterations improved within 24 hours after discontinuation of salbutamol. Conclusions We reinforce the message that even the use of intermittent nebulized salbutamol for acute moderate asthma can lead to severe transient complications in children. Then, healthcare providers should pay attention not only in emergency settings, to achieve prompt recognition and proper management of this adverse reaction. Careful reassessment could prevent similar reactions.https://doi.org/10.1186/s13256-022-03357-zAsthma exacerbationsSalbutamol adverse drug reactionLactic acidosisDiastolic hypotension
spellingShingle Marco Colombo
Anna Plebani
Annalisa Bosco
Massimo Agosti
Severe lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child: a case report
Journal of Medical Case Reports
Asthma exacerbations
Salbutamol adverse drug reaction
Lactic acidosis
Diastolic hypotension
title Severe lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child: a case report
title_full Severe lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child: a case report
title_fullStr Severe lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child: a case report
title_full_unstemmed Severe lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child: a case report
title_short Severe lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child: a case report
title_sort severe lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child a case report
topic Asthma exacerbations
Salbutamol adverse drug reaction
Lactic acidosis
Diastolic hypotension
url https://doi.org/10.1186/s13256-022-03357-z
work_keys_str_mv AT marcocolombo severelacticacidosisandpersistentdiastolichypotensionfollowingstandarddoseofintermittentnebulizedsalbutamolinachildacasereport
AT annaplebani severelacticacidosisandpersistentdiastolichypotensionfollowingstandarddoseofintermittentnebulizedsalbutamolinachildacasereport
AT annalisabosco severelacticacidosisandpersistentdiastolichypotensionfollowingstandarddoseofintermittentnebulizedsalbutamolinachildacasereport
AT massimoagosti severelacticacidosisandpersistentdiastolichypotensionfollowingstandarddoseofintermittentnebulizedsalbutamolinachildacasereport